- Presentations
- 3
- Markets
- 1
Revuforj is a brand of Revumenib marketed by Syndax Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Revumenib
- Brand owner
- Syndax Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 110 mg tablet, 160 mg tablet, 25 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Revuforj 110 mg tabletOral | Syndax Pharmaceuticals | US FDA | Available on request |
| Revuforj 160 mg tabletOral | Syndax Pharmaceuticals | US FDA | Available on request |
| Revuforj 25 mg tabletOral | Syndax Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Revuforj
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.